Biotech News

Sanofi: Information concerning the total number of voting rights and shares - October 2026

Sanofi (SNY)SanofiCommercial

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)

Related news

Sanofi

Global Biopharmaceutical Company Sanofi is a global biopharmaceutical company with major businesses in specialty medicines and vaccines. Its research and commercial portfolio is concentrated in immunology, rare diseases, hematology, neurology, oncology, and infectious-disease prevention. Dupixent-Led Immunology Franchise Dupixent,...

Recent company news

Stock data

Close
46.06 USD
Market cap
102.45B USD
Exchange
NASDAQ
Sector
Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines
Location
United States